Question to the Foreign, Commonwealth & Development Office:

To ask the Secretary of State for Foreign, Commonwealth and Development Affairs, what steps he is taking to help support the roll-out of UK-made malaria vaccines.

The UK is Gavi's largest investor, committing £1.65 billion to the current strategic period covering 2021-2025. Gavi coordinates the global malaria vaccination (RTS,S and R21) programme, providing essential financial support for the procurement, transport and roll-out of doses. To date, Gavi has supported 20 African countries in integrating the malaria vaccine into routine immunisation programmes. By collaborating with countries and partners, Gavi ensures the delivery of malaria vaccines as part of a comprehensive malaria control strategy. In addition to our support to Gavi the Foreign, Commonwealth, and Development Office and the UK Research and Innovation's Medical Research Council are funding applied research to support the effective rollout of malaria vaccines including how to best combine the vaccines with existing interventions.